The leader in needle-free auto-injection
for life-threatening emergency situations
CROSSJECT is a specialty pharmaceutical company revolutionizing the delivery of rapid-acting emergency medications through ZENEO®, its safe and reliable needle-free auto-injector designed for critical situations.
ZENEO® is a needle-free, pre-filled,
single-use auto-injector
Needle-free, fast, reliable, safe and very easy to use
ZENEO®
Technology
The ZENEO® technology is the foundation of our innovative solutions.
Therapeutic areas
Our product pipeline
About Crossject
CROSSJECT is revolutionizing drug delivery
-
Read the press release (PDF, new tab)
-
Read the press release (PDF, new tab)
CROSSJECT Reports Its First-Half 2026 results
-
Read the press release (PDF, new tab)
CROSSJECT and BARDA align ZEPIZURE®’s Pediatric development plan with FDA including funding through 2030
-
Read the press release (PDF, new tab)
CROSSJECT announces the successful completion of an equity financing